iRhythm Technologies Inc (IRTC)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.05B
Last updated: Nov 17, 2026 at 11:06 AM ET
iRhythm Technologies Inc (IRTC) P/E Ratio & Valuation Multiples
iRhythm Technologies (IRTC) trades at 74.5x trailing earnings and 3.5x sales. Its P/S of 3.5x is below its 5-year median of 6.9x. Its forward P/E is 54.6x. The median P/E across 9 similar companies is 23.9x.
Current Multiples
Its forward P/E is below its trailing P/E, which implies earnings per share about 36.4% higher over the next year. Its free cash flow yield is 0.2%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 74.5x |
| Forward P/E | 54.6x |
| Price to sales | 3.5x |
| Price to book | 17.0x |
| Price to FCF | 407.3x |
| EV/FCF | 442.2x |
| PEG | N/A |
| FCF yield | 0.2% |
Historical Medians
Against its 10-year medians, its P/S is 57.8% below 8.3x and its P/B is 9.6% below 18.8x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 3.5x | 6.9x | 8.3x |
| P/B | 17.0x | 21.0x | 18.8x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 2.1x in 2016 to 24.9x in 2020.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $177.44 | 7.7x | 38.7x |
| 2024 | $90.17 | 4.8x | 31.1x |
| 2023 | $107.04 | 6.6x | 15.6x |
| 2022 | $93.67 | 6.8x | 11.8x |
| 2021 | $117.69 | 10.7x | 12.4x |
| 2020 | $237.21 | 24.9x | 20.1x |
| 2019 | $68.09 | 8.0x | 13.4x |
| 2018 | $69.48 | 11.3x | 31.0x |
| 2017 | $56.05 | 12.8x | 16.3x |
| 2016 | $30.00 | 2.1x | 5.4x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IRTC
What is IRTC's forward P/E ratio?
iRhythm Technologies has a forward P/E ratio of 54.6x.
Is IRTC stock overvalued?
GNG's valuation label for IRTC is Undervalued. Its P/E of 74.5x compares with a median of 23.9x across 9 similar companies.
What is IRTC's price to sales ratio?
iRhythm Technologies has a price to sales ratio of 3.5x.
IRTC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors